Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shirley

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Topics in Geriatric Rehabilitation|August 9, 2021
Clinical-Community Connections: Incorporating Evidence-Based Programs for Improved Patient OutcomesLori A Schrodt, Rachel A Sledge, Colleen Hergott, et al.
Journal of Clinical Microbiology|January 30, 2023
<i>Leptotrichia</i> Bacteremia: 10-Year Retrospective Clinical Analysis and Antimicrobial Susceptibility ProfilesNischal Ranganath, Joshua D Shirley, Douglas W Challener, et al.
ACS Chemical Biology|September 29, 2022
Combined Structural Analysis and Molecular Dynamics Reveal Penicillin-Binding Protein Inhibition Mode with β-LactonesParker L Flanders, Carlos Contreras-Martel, Nathaniel W Brown, et al.
The New England Journal of Medicine|May 10, 2013
Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQMatthew D Shirley, Hao Tang, Carol J Gallione, et al.
Journal of Pediatric Orthopedics|January 11, 2019
Growth-Friendly Spine Surgery in Escobar SyndromeAdam Margalit, Paul D Sponseller, Richard E McCarthy, et al.
Molecular Cancer Research : MCR|March 12, 2021
RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell ProliferationMatthew S Crowe, Tatiana Zavorotinskaya, Charles F Voliva, et al.
Molecular Cancer Research : MCR|September 12, 2018
Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant MelanomaGrace P Leung, Tianshu Feng, Frederic D Sigoillot, et al.
Cancer|September 26, 2000
A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapyG M Mead, N M Bleehen, A Gregor, et al.
Frontiers in Nutrition|May 24, 2017
Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding TrialsNicholas D Embleton, Janet E Berrington, Jon Dorling, et al.
British Journal of Cancer|January 9, 2023
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanomaS Piperno-Neumann, M S Carlino, V Boni, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Topics in Geriatric Rehabilitation|August 9, 2021
Clinical-Community Connections: Incorporating Evidence-Based Programs for Improved Patient OutcomesLori A Schrodt, Rachel A Sledge, Colleen Hergott, et al.
Journal of Clinical Microbiology|January 30, 2023
<i>Leptotrichia</i> Bacteremia: 10-Year Retrospective Clinical Analysis and Antimicrobial Susceptibility ProfilesNischal Ranganath, Joshua D Shirley, Douglas W Challener, et al.
ACS Chemical Biology|September 29, 2022
Combined Structural Analysis and Molecular Dynamics Reveal Penicillin-Binding Protein Inhibition Mode with β-LactonesParker L Flanders, Carlos Contreras-Martel, Nathaniel W Brown, et al.
The New England Journal of Medicine|May 10, 2013
Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQMatthew D Shirley, Hao Tang, Carol J Gallione, et al.
Journal of Pediatric Orthopedics|January 11, 2019
Growth-Friendly Spine Surgery in Escobar SyndromeAdam Margalit, Paul D Sponseller, Richard E McCarthy, et al.
Molecular Cancer Research : MCR|March 12, 2021
RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell ProliferationMatthew S Crowe, Tatiana Zavorotinskaya, Charles F Voliva, et al.
Molecular Cancer Research : MCR|September 12, 2018
Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant MelanomaGrace P Leung, Tianshu Feng, Frederic D Sigoillot, et al.
Cancer|September 26, 2000
A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapyG M Mead, N M Bleehen, A Gregor, et al.
Frontiers in Nutrition|May 24, 2017
Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding TrialsNicholas D Embleton, Janet E Berrington, Jon Dorling, et al.
British Journal of Cancer|January 9, 2023
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanomaS Piperno-Neumann, M S Carlino, V Boni, et al.
Pageof 8